Variant report
Variant | esv2604566 |
---|---|
Chromosome Location | chr12:86522207-86523968 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536861604 | chr12:86522640-86522641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548344763 | chr12:86522642-86522643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557928038 | chr12:86522662-86522663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368312006 | chr12:86522685-86522686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569838720 | chr12:86522710-86522711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537015807 | chr12:86522724-86522725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558515432 | chr12:86522752-86522753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186621432 | chr12:86522757-86522758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs60587165 | chr12:86522775-86522776 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs839180 | chr12:86522782-86522783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs574508495 | chr12:86522788-86522789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542012826 | chr12:86522809-86522810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576016490 | chr12:86522851-86522852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575394327 | chr12:86523001-86523002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs193286635 | chr12:86523059-86523060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564066127 | chr12:86523069-86523070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs839181 | chr12:86523093-86523094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185464935 | chr12:86523127-86523128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs863397 | chr12:86523259-86523260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4586245 | chr12:86523266-86523267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs7487426 | chr12:86523278-86523279 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs553208894 | chr12:86523281-86523282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35391935 | chr12:86523282-86523283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201950203 | chr12:86523326-86523327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200409663 | chr12:86523327-86523328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201156233 | chr12:86523328-86523329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148572792 | chr12:86523623-86523624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199769772 | chr12:86523635-86523636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142926647 | chr12:86523708-86523709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146110032 | chr12:86523709-86523710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188740122 | chr12:86523724-86523725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74405472 | chr12:86523804-86523805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12815148 | chr12:86523808-86523809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140190507 | chr12:86523841-86523842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143873424 | chr12:86523850-86523851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146431743 | chr12:86523869-86523870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557171320 | chr12:86523892-86523893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541187014 | chr12:86523944-86523945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:86522600-86523400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr12:86523400-86528200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |